Literature DB >> 29602278

DARK Classics in Chemical Neuroscience: Methamphetamine.

Thomas J Abbruscato1, Paul C Trippier1.   

Abstract

Methamphetamine has the second highest prevalence of drug abuse after cannabis, with estimates of 35 million users worldwide. The ( S)-(+)-enantiomer is the illicit drug, active neurostimulant, and eutomer, while the ( R)-(-)-enantiomer is contained in over the counter decongestants. While designated a schedule II drug in 1970, ( S)-(+)-methamphetamine is available by prescription for the treatment of attention-deficit disorder and obesity. The illicit use of ( S)-(+)-methamphetamine results in the sudden "rush" of stimulation to the motivation, movement, pleasure, and reward centers in the brain, caused by rapid release of dopamine. In this review, we will provide an overview of the synthesis, pharmacology, adverse effects, and drug metabolism of this widely abused psychostimulant that distinguish it as a DARK classic in Chemical Neuroscience.

Entities:  

Keywords:  Methamphetamine; drug of abuse; psychoactive; stimulant

Mesh:

Substances:

Year:  2018        PMID: 29602278     DOI: 10.1021/acschemneuro.8b00123

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  9 in total

1.  Viloxazine, a Non-stimulant Norepinephrine Reuptake Inhibitor, for the Treatment of Attention Deficit Hyperactivity Disorder: A 3 Year Update.

Authors:  Hannah W Haddad; Paul B Hankey; Jimin Ko; Zahaan Eswani; Pravjit Bhatti; Amber N Edinoff; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-07-28

2.  Optogenetic Stimulation of Midbrain Dopamine Neurons Produces Striatal Serotonin Release.

Authors:  Merel Dagher; Katie A Perrotta; Sara A Erwin; Ayaka Hachisuka; Rahul Iyer; Sotiris C Masmanidis; Hongyan Yang; Anne M Andrews
Journal:  ACS Chem Neurosci       Date:  2022-03-21       Impact factor: 5.780

3.  Early onset cardiovascular disease related to methamphetamine use is most striking in individuals under 30: A retrospective chart review.

Authors:  Vinita Batra; Kevin S Murnane; Brianne Knox; Amber N Edinoff; Yahya Ghaffar; Laura Nussdorf; Murray Petersen; Sarah E Kaufman; Sania Jiwani; Christopher A Casey; Stephanie Terhoeve; Mohammad Alfrad Nobel Bhuiyan; Paari Dominic; Shawn McNeil; James Patterson
Journal:  Addict Behav Rep       Date:  2022-05-18

Review 4.  Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction.

Authors:  Christopher M Jones; Debra Houry; Beth Han; Grant Baldwin; Alana Vivolo-Kantor; Wilson M Compton
Journal:  Ann N Y Acad Sci       Date:  2021-09-24       Impact factor: 6.499

5.  Verbal learning impairment in adolescents with methamphetamine use disorder: a cross-sectional study.

Authors:  Lukas Andreas Basedow; Sören Kuitunen-Paul; Melina Felicitas Wiedmann; Stefan Ehrlich; Veit Roessner; Yulia Golub
Journal:  BMC Psychiatry       Date:  2021-03-25       Impact factor: 3.630

6.  Metabolomics profiling of methamphetamine addicted human serum and three rat brain areas.

Authors:  Ming Lin; Jiamin Xu; Xi Liu; Zhenfeng Dai; Zhimin Liu; Xin Zhao; Yi Sun; Xiaoping Pu
Journal:  RSC Adv       Date:  2019-12-12       Impact factor: 4.036

Review 7.  The Role and Therapeutic Potential of Macropinocytosis in Cancer.

Authors:  Zejing Qiu; Wencheng Liu; Qianru Zhu; Kun Ke; Qicong Zhu; Weiwei Jin; Shuxian Yu; Zuyi Yang; Lin Li; Xiaochen Sun; Shuyi Ren; Yanfen Liu; Zhiyu Zhu; Jiangping Zeng; Xiaoyu Huang; Yan Huang; Lu Wei; Mengmeng Ma; Jun Lu; Xiaoyang Chen; Yiping Mou; Tian Xie; Xinbing Sui
Journal:  Front Pharmacol       Date:  2022-08-15       Impact factor: 5.988

8.  Effects of moderate-intensity exercise on social health and physical and mental health of methamphetamine-dependent individuals: A randomized controlled trial.

Authors:  Jisheng Xu; Zhicheng Zhu; Xin Liang; Qiuyue Huang; TianZhen Zheng; Xue Li
Journal:  Front Psychiatry       Date:  2022-09-23       Impact factor: 5.435

9.  Methamphetamine Increases the Proportion of SIV-Infected Microglia/Macrophages, Alters Metabolic Pathways, and Elevates Cell Death Pathways: A Single-Cell Analysis.

Authors:  Meng Niu; Brenda Morsey; Benjamin G Lamberty; Katy Emanuel; Fang Yu; Rosiris León-Rivera; Joan W Berman; Peter J Gaskill; Stephanie M Matt; Pawel S Ciborowski; Howard S Fox
Journal:  Viruses       Date:  2020-11-12       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.